Related Experiment Video
Updated: Jun 10, 2026

Integration of Wet and Dry Bench Processes Optimizes Targeted Next-generation Sequencing of Low-quality and Low-quantity Tumor Biopsies
Published on: April 11, 2016
Molecular tools: biology, prognosis, and therapeutic triage
Ingeborg Fischer1, Kenneth Aldape
1Department of Pathology, Unit 085, The University of Texas M.D. Anderson Cancer Center, 1515 Holcombe Boulevard, Houston, TX 77030, USA.
Abstract:
Diffuse gliomas in adults continue to have a dismal prognosis with the current standard therapeutic methods, including maximal surgical resection, radiation, and chemotherapy. The pathogenesis of adult glioma is complex, involving the loss of function of tumor suppressor genes and activation of oncogenes, which are involved in a network of interconnected signaling pathways. Through activation of these pathways, characteristics of malignant gliomas, including uncontrolled proliferation and growth, invasion, and angiogenesis, are driven. Evolving therapeutic approaches are focused on specifically targeting these genetic lesions. This content gives an overview of the current knowledge about the pathogenesis of adult diffuse gliomas, emphasizing new targeted treatment approaches.
Insights
Adult diffuse gliomas have a poor prognosis. New targeted therapies aim to disrupt the complex signaling pathways driving glioma growth and invasion, offering improved treatment strategies.
Area of Science:
- Neuro-oncology
- Molecular Biology
- Cancer Genetics
Background:
- Adult diffuse gliomas present a significant therapeutic challenge with limited survival rates.
- Current treatments (surgery, radiation, chemotherapy) offer suboptimal outcomes.
- Glioma pathogenesis involves intricate genetic mutations and dysregulated signaling pathways.
Purpose of the Study:
- To provide an overview of the pathogenesis of adult diffuse gliomas.
- To highlight emerging targeted treatment strategies.
- To discuss the molecular mechanisms underlying glioma progression.
Main Methods:
- Review of current literature on glioma pathogenesis.
- Analysis of genetic alterations and signaling pathways in diffuse gliomas.
- Exploration of novel targeted therapeutic agents and approaches.
Main Results:
- Diffuse gliomas are driven by complex genetic alterations affecting tumor suppressor genes and oncogenes.
- Interconnected signaling pathways are crucial for uncontrolled proliferation, invasion, and angiogenesis.
- Targeting specific genetic lesions shows promise for improved therapeutic efficacy.
Conclusions:
- Understanding glioma pathogenesis is key to developing effective treatments.
- Targeted therapies represent a promising frontier for adult diffuse glioma management.
- Further research into molecular pathways will refine treatment strategies.
More Related Videos
09:33Genetic Profiling and Genome-Scale Dropout Screening to Identify Therapeutic Targets in Mouse Models of Malignant Peripheral Nerve Sheath Tumor
Published on: August 25, 2023
03:08Using Human Differentially Expressed Gene Lists to Perform Downstream Pathway Enrichment Analysis and Target Prioritization
Published on: October 3, 2025
Related Concept Videos
Combination Therapies and Personalized Medicine
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
Targeted Cancer Therapies
There are several types of targeted therapies against specific...
Targeted Cancer Therapies
There are several types of targeted therapies against specific...
Modern Molecular Taxonomy
Tumor Progression
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
Applications of Molecular Taxonomy